WSM

Consensus

Buy3.56 / 518 ratings · Strong Buy 0 · Buy 10 · Hold 8 · Sell 0 · Strong Sell 0
Avg target $246.31+2.4%Median $253.00High $275.00Low $190.0013 targets in the last 12 months1 rating older than 2 years not counted

Price vs average target

Revenue and EPS estimates

ReportedConsensus estimates
Fiscal periodFY2024Jan '24FY2025Jan '25FY2026Jan '26FY2027Jan '27FY2028Jan '28FY2029Jan '29
Revenue (B)7.757.717.818.278.719.16
Growth YoY−10.6%−0.5%+1.2%+6.0%+5.3%+5.2%
High estimate–––8.358.879.29
Low estimate–––8.158.548.99
Analysts–––16168
EPS, adjusted7.439.028.859.5110.5111.58
Growth YoY−26.1%+21.4%−1.9%+7.4%+10.6%+10.1%
High estimate–––9.7011.0412.31
Low estimate–––9.3510.1211.19
Analysts–––12125

Consensus mean of analyst estimates. EPS is adjusted (street) EPS, the basis analysts forecast; annual actuals are the sum of the four reported quarters. Growth compares with the same period a year earlier; n/m where the prior period was a loss.

Brokers

19 firms active in the last 12 months
FirmAnalystRatingPrev ratingTargetPrev targetChgUpsideDate
Evercore ISI Group–In LineIn Line$245.00$240.00+2%+2%Sep 9
Argus ResearchChristopher GrajaBuyBuy$250.00$230.00+9%+4%Sep 2
Citigroup–NeutralNeutral––––Aug 27
Guggenheim–NeutralNeutral––––Aug 27
KeyBanc–OverweightOverweight$270.00$250.00+8%+12%Aug 27
Morgan Stanley–Equal WeightEqual Weight$240.00$210.00+14%0%Aug 27
RBC CapitalSteven ShemeshOutperformOutperform$260.00$192.00+35%+8%Aug 27
Telsey AdvisoryCristina FernandezOutperform · Aug 2026Outperform$260.00$255.00+2%+8%Aug 27
UBSMichael LasserNeutralNeutral$247.00$175.00+41%+3%Aug 27
Jefferies–Buy · Mar 2025Buy$275.00$156.00+76%+14%Aug 26
B of A Securities–BuyBuy––––Aug 24
Credit Suisse–Underperform · Aug 2021 · not countedUnderperform$261.00$77.50+237%+9%Aug 24
Goldman SachsKate McShaneBuyBuy$261.00$143.50+82%+9%Aug 11
Wells Fargo–Equal WeightEqual Weight$190.00$185.00+3%−21%Aug 11
Piper SandlerPeter KeithOverweightNeutral$253.00––+5%Jul 27
Barclays–Equal WeightEqual Weight$190.00$166.00+14%−21%May 22
Baird–OutperformOutperform––––Mar 19
TD Cowen–BuyBuy––––Mar 19
Zelman & Assoc–NeutralUnderperform––––Jan 29

Latest analyst action Page refreshed hourly; analyst feeds refreshed dailyAbout this data

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.